The Use of Stimulant Medication to Treat Neurocognitive Deficits in Patients with Pediatric Cancer, Traumatic Brain Injury, and Sickle Cell Disease: A Review

References

• . Askins MA, Moore BD 3rd. Preventing neurocognitive late effects in childhood cancer survivors. J Child Neurol. 2008;23(10): 1160–1171
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention (CDC). Chronic Diseases: The Power to Prevent, the Call to Control. Atlanta, GA: National Center for Chronic Disease Prevention and Health Promotion; 2009
   Google Scholar
• . Catroppa C, Anderson VA, Morse SA, Haritou F, Rosenfeld JV. Outcome and predictors of functional recovery 5 years following pediatric traumatic brain injury (TBI). J Pediatr Psychol. 2008;33(7): 707–718
   PubMed Web of Science ®Google Scholar
• . Daly BP, Kral MC, Brown RT. Cognitive and academic problems associated with childhood cancers and sickle-cell disease. School Psychol Q. 2008;23(2):230–242
   Web of Science ®Google Scholar
• . Krull KR, Brouwers P, Jain N, . Folate pathway genetic polymorphisms are related to attention disorders in childhood leukemia survivors. J Pediatr. 2008;152(1):101–105
   PubMed Web of Science ®Google Scholar
• . Mulhern RK, Butler RW. Neurocognitive sequelae of childhood cancers and their treatment. Pediatr Rehabil. 2004;7(1):1–14; discussion 15–16
   PubMedGoogle Scholar
• . Mitby PA, Robison LL, Whitton JA, ; Childhood Cancer Survivor Study Steering Committee. Utilization of special education services and educational attainment among long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2003;97(4):1115–1126
   PubMed Web of Science ®Google Scholar
• . Hijmans CT, Fijnvandraat K, Grootenhuis MA, . Neurocognitive deficits in children with sickle cell disease: a comprehensive profile. Pediatr Blood Cancer. 2011;56(5):783–788
   PubMed Web of Science ®Google Scholar
• . Daly BP, Brown RT. Scholarly literature review: management of neurocognitive late effects with stimulant medication. J Pediatr Psychol. 2007;32(9):1111–1126
   PubMed Web of Science ®Google Scholar
• . American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 2000
   Google Scholar
• . Butler RW, Mulhern RK. Neurocognitive interventions for children and adolescents surviving cancer. J Pediatr Psychol. 2005;30(1):65–78
   PubMed Web of Science ®Google Scholar
• . Anderson FS, Kunin–Batson AS. Neurocognitive late effects of chemotherapy in children: the past 10 years of research on brain structure and function. Pediatr Blood Cancer. 2009;52(2):159–164
   PubMed Web of Science ®Google Scholar
• . Barkley RA. ADHD and the Nature of Self-Control. New York, NY: Guilford Press; 1997
   Google Scholar
• . Rothbart MK, Posner MI. Mechanism and variation in the development of attentional networks. In: Nelson CA, Luciana M, eds. Handbook of Developmental Cognitive Neuroscience. Cambridge, MA: MIT Press; 2001:353–363
   Google Scholar
• . Arnsten AF. Stimulants: therapeutic actions in ADHD. Neuropsychopharmacology. 2006;31(11):2376–2383
   PubMed Web of Science ®Google Scholar
• . Thompson–Schill SL, Ramscar M, Chrysikou EG. Cognition without control: when a little frontal lobe goes a long way. Curr Dir Psychol Sci. 2009;18(5):259–263
   PubMed Web of Science ®Google Scholar
• . Wehmeier PM, Schacht A, Barkley RA. Social and emotional impairment in children and adolescents with ADHD and the impact on quality of life. J Adolesc Health. 2010;46(3):209–217
   PubMed Web of Science ®Google Scholar
• . Brown RT, Daly BP. Neuropsychological effects of stimulant medication on children's learning and behavior. In: Reynolds CR, Fletcher–Janzen E, eds. Handbook of Clinical Child Neuropsychology. 3rd ed. New York, NY: Plenum; 2009:529–580
   Google Scholar
• . Brown RT, Sleator EK. Methylphenidate in hyperkinetic children: differences in dose effects on impulsive behavior. Pediatrics. 1979; 64(4):408–411
   PubMed Web of Science ®Google Scholar
• . Sprague RL, Sleator EK. Methylphenidate in hyperkinetic children: differences in dose effects on learning and social behavior. Science. 1977;198(4323):1274–1276
   PubMed Web of Science ®Google Scholar
• . American Academy of Pediatrics Subcommittee on Attention-deficit/Hyperactivity Disorder and Committee on Quality Improvement Clinical practice guideline: treatment of the school-aged child with attention-deficit/hyperactivity disorder. Pediatrics. 2001;108(4):1033–1044
   PubMed Web of Science ®Google Scholar
• . Greenhill LL, Pliszka S, Dulcan MK, . Summary of the practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry. 2002;40(11):1352–1355
   Web of Science ®Google Scholar
• . Jensen PS, Hinshaw SP, Swanson JM, . Findings from the NIMH Multimodal Treatment Study (MTA): implications and applications for primary care providers. Dev Behav Pediatr. 2001;22(1):60–73
   PubMed Web of Science ®Google Scholar
• . Greenhill LL, Swanson JM, Vitiello B, . Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial. J Am Acad Child Adolesc Psychiatry. 2001;40(2):180–187
   PubMed Web of Science ®Google Scholar
• . Childress AC, Spender T, Lopez F, . Efficacy and safety of dexmethylphenidate extended-release capsules administered once daily to children with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2008;19(4):351–361
   Web of Science ®Google Scholar
• . Rapport MD, Moffitt C. Attention deficit/hyperactivity disorder and methylphenidate. A review of height/weight, cardiovascular, and complaint side effects. Clin Psychol Rev. 2002;22(8): 1107–1131
   PubMed Web of Science ®Google Scholar
• . Daly BP, Kral MC, Brown RT, . Ameliorating attention problems in children with sickle cell disease: a pilot study of methylphenidate. J Dev Behav Pediatr. 2012;33(3):244–251
   PubMed Web of Science ®Google Scholar
• . Whyte J, Hart T, Vaccaro M, . Effects of methylphenidate on attention deficits after traumatic brain injury: a multidimensional, randomized, controlled trial. Am J Phys Med Rehabil. 2004;83(6): 401–420
   PubMed Web of Science ®Google Scholar
• . Ward MW, Goldman M, Delagdo I, . Psychological functioning and psychotropic medication use in childhood cancer survivors. Poster presented at: National Conference on Child Health Psychology; April 10–12, 2008; Miami, FL
   Google Scholar
• . Siegel R, Desantis C, Virgo K, . Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–241
   PubMed Web of Science ®Google Scholar
• . Strother DR, Pollack IF, Fisher PG, . Tumors of the central nervous system. In: Pizzo PA, Poplak DG, eds. Principles and Practice of Pediatric Oncology. 4th ed. Philadelphia, PA: Lippincott, Williams and Wilkins; 2002:751–824
   Google Scholar
• . American Cancer Society website. Cancer in children. http://www.cancer.org/Cancer/CancerinChildren/DetailedGuide/cancer-in-children-types-of-childhood-cancers. Accessed July 1, 2012
   Google Scholar
• . Butler RW, Haser JK. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev. 2006;12(3):184–191
   PubMedGoogle Scholar
• . Miketova P, Kaemingk K, Hockenberry M, . Oxidative changes in cerebral spinal fluid phosphatidylcholine during treatment for acute lymphoblastic leukemia. Biol Res Nurs. 2005;6(3):187–195
   PubMedGoogle Scholar
• . Brown RT, Buchanan I, Doepke K, . Cognitive and academic functioning in children with sickle-cell disease. J Clin Child Psychol. 1993;22(2):207–218
   Web of Science ®Google Scholar
• . Mulhern RK, Hancock J, Fairclough D, Kun L. Neuropsychological status of children treated for brain tumors: a critical review and integrative analysis. Med Pediatr Oncol. 1992;20(3):181–191
   PubMedGoogle Scholar
• . Cohen BH, Packer RJ, Siegel KR, . Brain tumors in children under 2 years: treatment, survival and long-term prognosis. Pediatr NeuroSurg. 1993;19(4):171–179
   PubMed Web of Science ®Google Scholar
• . Packer RJ, Sposto R, Atkins TE, . Quality of life in children with primitive neuroectodermal tumors (medulloblastoma) of the posterior fossa. Pediatr NeuroSci. 1987;13(4):169–175
   PubMed Web of Science ®Google Scholar
• . Conklin HM, Khan RB, Reddick WE, . Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediatr Psychol. 2007; 32(9):1127–1139
   PubMed Web of Science ®Google Scholar
• . Thompson SJ, Leigh L, Christensen R, . Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol. 2001;19(6):1802–1808
   PubMed Web of Science ®Google Scholar
• . Mulhern RK, Khan RB, Kaplan S, . Short-term efficacy of methylphenidate: a randomized, double-blind, placebo-controlled trial among survivors of childhood cancer. J Clin Oncol. 2004;22(23): 4795–4803
   PubMed Web of Science ®Google Scholar
• . Netson KL, Conklin HM, Ashford JM, Kahalley LS, Wu SW, Xiong X. Parent and teacher ratings of attention during a year-long methylphenidate trial in children treated for cancer. J Pediatr Psychol. 2011;36(4):438–450
   PubMed Web of Science ®Google Scholar
• . Conklin HM, Helton S, Ashford J, . Predicting methylphenidate response in long-term survivors of childhood cancer: a randomized, double-blind, placebo-controlled, crossover trial. J Pediatr Psychol. 2010;35(2):144–155
   PubMed Web of Science ®Google Scholar
• . Conklin HM, Reddick WE, Ashford J, . Long-term efficacy of methylphenidate in enhancing attention regulation, social skills, and academic abilities of childhood cancer survivors. J Clin Oncol. 2010;28(29):4465–4472
   PubMed Web of Science ®Google Scholar
• . Weiss G, Hechtmann LT. Medication treatment of ADHD. In: Weiss G, Hechtmann LT, eds. Hyperactive Children Grown Up. 2nd ed. New York, NY: Guilford Press; 1993:348–365
   Google Scholar
• . Meyers CA, Weitzner MA, Valentine AD, Levin VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol. 1998;16(7):2522–2527
   PubMed Web of Science ®Google Scholar
• . Conklin HM, Lawford J, Jasper BW, . Side effects of methylpheni-date in childhood cancer survivors: a randomized placebo-controlled trial. Pediatrics. 2009;124(1):226–233
   PubMed Web of Science ®Google Scholar
• . Ornstein TJ, Levin HS, Chen S, . Performance monitoring in children following traumatic brain injury. J Child Psychol Psychiatry. 2009;50(4):506–513
   PubMed Web of Science ®Google Scholar
• . Jin C, Schachar R. Methylphenidate treatment of attention-deficit/hyperactivity disorder secondary to traumatic brain injury: a critical appraisal of treatment studies. CNS Spectr. 2004;9(3):217–226
   PubMed Web of Science ®Google Scholar
• . Rehabilitation of persons with traumatic brain injury. NIH Consens Statement. 1998;16(1):1–41
   PubMedGoogle Scholar
• . Langlois JA, Rutland–Brown W, Thomas KE. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Atlanta, GA: US Dept of Health and Human Services; Centers for Disease Control and Prevention; National Center for Injury Prevention and Control; 2006
   Google Scholar
• . Langlois JA, Gotsch KE. Traumatic Brain Injury in the United States: Assessing Outcomes in Children. Atlanta, GA: National Center for Injury Prevention and Control; Centers for Disease Control and Prevention; 2001
   Google Scholar
• . Yeates KO. Closed-head injury. In: Yeats KO, Ris MD, Taylor HG, eds. Pediatric Neuropsychology: Research, Theory, and Practice. New York, NY: Guilford Press; 2000:92–116
   Google Scholar
• . Pangilinan PH, Giacoletti–Argento A, Shellhaas R, Hurvitz EA, Hornyak JE. Neuropharmacology in pediatric brain injury: a review. PMR. 2010;2(12):1127–1140
   PubMedGoogle Scholar
• . Bates G. Medication in the treatment of the behavioural sequelae of traumatic brain injury. Dev Med Child Neurol. 2006;48(8): 697–701
   PubMed Web of Science ®Google Scholar
• . Ylvisaker M, Adelson PD, Braga LW, . Rehabilitation and ongoing support after pediatric TBI: twenty years of progress. J Head Trauma Rehabil. 2005;20(1):95–109
   PubMed Web of Science ®Google Scholar
• . Anderson V, Yeates KO. Pediatric Traumatic Brain Injury: New Frontiers in Clinical and Translational Research. New York, NY: Cambridge University Press; 2010
   Google Scholar
• . Beers SR, Skold A, Dixon CE, Adelson PD. Neurobehavioral effects of amantadine after pediatric traumatic brain injury: a preliminary report. J Head Trauma Rehabil. 2005;20(5):450–463
   PubMed Web of Science ®Google Scholar
• . Hanten G, Bartha M, Levin HS. Metacognition following pediatric traumatic brain injury: a preliminary study. Dev Neuropsychol. 2000; 18(3):383–398
   PubMed Web of Science ®Google Scholar
• . Bigler ED. Quantitative magnetic resonance imaging in traumatic brain injury. J Head Trauma Rehabil. 2001;16(2):117–134
   PubMed Web of Science ®Google Scholar
• . Povlishock JT, Katz DI. Update of neuropathology and neurological recovery after traumatic brain injury. J Head Trauma Rehabil. 2005; 20(1):76–94
   PubMed Web of Science ®Google Scholar
• . Gerring JP, Brady KD, Chen A, . Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Acad Child Adolesc Psychiatry. 1998;37(6):647–654
   PubMed Web of Science ®Google Scholar
• . Max JE, Lindgren SD, Knutson C, Pearson CS, Ihrig D, Welborn A. Child and adolescent traumatic brain injury: correlates of injury severity. Brain InJ. 1998;12(1):31–40
   PubMed Web of Science ®Google Scholar
• . Max JE, Roberts MA, Koele SL, . Cognitive outcome in children and adolescents following severe traumatic brain injury: influence of psychosocial, psychiatric, and injury-related variables. J Int Neuropsychol Soc. 1999;5(1):58–68
   PubMed Web of Science ®Google Scholar
• . Farmer JE, Peterson L. Injury risk factors in children with attention deficit hyperactivity disorder. Health Psychol. 1995;14(4):325–332
   PubMed Web of Science ®Google Scholar
• . Gerring JP, Brady KD, Chen A, . Premorbid prevalence of ADHD and development of secondary ADHD after closed head injury. J Am Acad Child Adolesc Psychiatry. 1998;37(6):647–654
   PubMed Web of Science ®Google Scholar
• . Hornyak JE, Nelson VS, Hurvitz EA. The use of methylphenidate in paediatric traumatic brain injury. Pediatr Rehabil. 1997;1(1):15–17
   PubMedGoogle Scholar
• . Mahalick DM, Carmel PW, Greenberg JP, . Psychopharmacologic treatment of acquired attention disorders in children with brain injury. Pediatr NeuroSurg. 1998;29(3):121–126
   PubMed Web of Science ®Google Scholar
• . Siddall OM. Use of methylphenidate in traumatic brain injury. Ann Pharmacother. 2005;39(7–8):1309–1313
   PubMed Web of Science ®Google Scholar
• . Williams SE, Ris MD, Ayyangar R, Scheffi BK, Berch D. Recovery in pediatric brain injury: is psychostimulant medication beneficial? J Head Trauma Rehabil. 1998;13(3):73–81
   PubMed Web of Science ®Google Scholar
• . Hassell KL. Population estimates of sickle cell disease in the U.S. Am J Prev Med. 2010;38( 4 suppl):S512–S521
   PubMed Web of Science ®Google Scholar
• . Centers for Disease Control and Prevention (CDC) website. Sickle cell disease. Data and statistics. http://www.cdc.gov/NCBDDD/sicklecell/data.html. Updated September 16, 2011. Accessed July 1, 2012
   Google Scholar
• . Daly B, Kral MC, Tarazi RA. The role of neuropsychological evaluation in pediatric sickle cell disease. Clin Neuropsychol. 2011;25(6):903–925
   PubMed Web of Science ®Google Scholar
• . Frenette PS, Atweh GF. Sickle cell disease: old discoveries, new concepts, and future promise. J Clin Invest. 2007;117(4):850–858
   PubMed Web of Science ®Google Scholar
• . Broderick J, Talbot GT, Prenger E, Leach A, Brott T. Stroke in children within a major metropolitan area: the surprising importance of intracerebral hemorrhage. J Child Neurol. 1993;8(3):250–255
   PubMed Web of Science ®Google Scholar
• . Fullerton HJ, Wu YW, Zhao S, Johnston SC. Risk of stroke in children: ethnic and gender disparities. Neurology. 2003;61(2):189–194
   PubMed Web of Science ®Google Scholar
• . Rees DC, Williams TN, Gladwin MT. Sickle-cell disease. Lancet. 2010;376(9757):2018–2031
   PubMed Web of Science ®Google Scholar
• . Serajee FJ, Sarnaik SA, Altinok D, Huq AH. Stroke in sickle cell disease. J Pediatr Neurol. 2010;8(3):299–310
   Google Scholar
• . Miller ST, Macklin EA, Pegelow CH, ; Cooperative Study of Sickle Cell Disease. Silent infarction as a risk factor for overt stroke in children with sickle cell anemia: a report from the Cooperative Study of Sickle Cell Disease. J Pediatr. 2001;139(3):385–390
   PubMed Web of Science ®Google Scholar
• . Ohene–Frempong K, Weiner SJ, Sleeper LA, . Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood. 1998; 91(1):288–294
   PubMed Web of Science ®Google Scholar
• . Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in a cohort of patients with homozygous sickle cell disease. J Pediatr. 1992;120(3):360–366
   PubMed Web of Science ®Google Scholar
• . Armstrong FD, Thompson RJ Jr, Wang W, . Cognitive functioning and brain magnetic resonance imaging in children with sickle cell disease. Neuropsychology Committee of the Cooperative Study of Sickle Cell Disease. Pediatrics. 1996;97(6 pt 1):864–870
   PubMed Web of Science ®Google Scholar
• . Berkelhammer LD, Williamson AL, Sanford SD, . Neurocognitive sequelae of pediatric sickle cell disease: a review of the literature. Child Neuropsychol. 2007;13(2):120–131
   PubMed Web of Science ®Google Scholar
• . Cohen MJ, Branch WB, McKie VC, Adams RJ. Neuropsychological impairment in children with sickle cell anemia and cerebrovascular accidents. Clin Pediatr (Phila). 1994;33(9):517–524
   PubMed Web of Science ®Google Scholar
• . DeBaun MR, Schatz J, Siegel MJ, . Cognitive screening examinations for silent cerebral infarcts in sickle cell disease. Neurology. 1998;50(6):1678–1682
   PubMed Web of Science ®Google Scholar
• . Tarazi RA, Grant ML, Ely E, Barakat LP. Neuropsychological functioning in preschool-age children with sickle cell disease: the role of illness-related and psychosocial factors. Child Neuropsychol. 2007;13(2): 155–172
   PubMed Web of Science ®Google Scholar
• . Steen RG, Xiong X, Mulhern RK, Langston JW, Wang WC. Subtle brain abnormalities in children with sickle cell disease: relationship to blood hematocrit. Ann Neurol. 1999;45(3):279–286
   PubMed Web of Science ®Google Scholar
• . Hogan AM, Pit–ten Cate IM, Vargha–Khadem F, Prengler M, Kirkham FJ. Physiological correlates of intellectual function in sickle cell disease: hypoxaemia, hyperaemia, and brain infarction. Dev Sci. 2006;9(4):379–387
   PubMed Web of Science ®Google Scholar
• . Kral MC, Brown RT, Nietert PJ, Abboud MR, Jackson SM, Hynd GW. Transcranial Doppler ultrasonography and neurocognitive functioning in children with sickle cell disease. Pediatrics. 2003;112(2): 324–331
   PubMed Web of Science ®Google Scholar
• . Brown RT, Davis PC, Lambert R, Hsu L, Hopkins K, Eckman J. Neurocognitive functioning and magnetic resonance imaging in children with sickle cell disease. J Pediatr Psychol. 2000;25(7): 503–513
   PubMed Web of Science ®Google Scholar
• . Pegelow CH, Macklin EA, Moser FG, . Longitudinal changes in brain magnetic resonance imaging findings in children with sickle cell disease. Blood. 2002;99(8):3014–3018
   PubMed Web of Science ®Google Scholar
• . Clark TD, Greenhouse B, Njama–Meva D, . Factors determining the heterogeneity of malaria incidence in children in Kampala, Uganda. J Infect Dis. 2008;198(3):393–400
   PubMed Web of Science ®Google Scholar
• . Rosenthal PJ. Lessons from sickle cell disease in the treatment and control of malaria. N Engl J Med. 2011;364(26):2549–2551
   PubMed Web of Science ®Google Scholar
• . Aron AR, Dowson JH, Sahakian BJ, Robbins TW. Methylphenidate improves response inhibition in adults with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2003;54(12):1465–1468
   PubMed Web of Science ®Google Scholar
• . Coghill DR, Rhodes SM, Matthews K. The neuropsychological effects of chronic methylphenidate on drug-naïve boys with attention-deficit/hyperactivity disorder. Biol Psychiatry. 2007;62(9):954–962
   PubMed Web of Science ®Google Scholar
• . Willcut EG, Doyle AE, Nigg JT, Faraone SV, Pennington BF. Validity of the executive function theory of attention-deficit/hyperactivity disorder: a meta-analytic review. Biol Psychiatry. 2005;57(11):1336–1346
   PubMed Web of Science ®Google Scholar
• . Jaekel J, Wolke D, Bartmann P. Poor attention rather than hyperactivity/impulsivity predicts academic achievement in very preterm and full-term adolescents [published online ahead of print May 21, 2012]. Psychol Med
   Google Scholar
• . Pinquart M, Teubert D. Academic, physical, and social functioning of children and adolescents with chronic physical illness: a meta-analysis. J Pediatr Psychol. 2012;37(4):376–389
   PubMed Web of Science ®Google Scholar
• . Max JE, Arndt S, Castillo CS, . Attention-deficit hyperactivity symptomatology after traumatic brain injury: a prospective study. J Am Acad Child Adolesc Psychiatry. 1998;37(8):841–847
   PubMed Web of Science ®Google Scholar
• . Schatz J. Brief report: academic attainment in children with sickle cell disease. J Pediatr Psychol. 2004;29(8):627–633
   PubMed Web of Science ®Google Scholar
• . Steinberg MH. Management of sickle cell disease. N Engl J Med. 1999;340(13):1021–1030
   PubMed Web of Science ®Google Scholar